Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

Background: Lung cancer is the most common cause of cancer-related deaths worldwide. Early diagnosis is crucial to increase the curability chance of the patients. Low dose CT screening can reduce lung cancer mortality, but it is associated with several limitations. Metabolomics is a promising techni...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Sandeep, Rolfo, Christian, Maksymiuk, Andrew W., Tappia, Paramjit S., Sitar, Daniel S., Russo, Alessandro, Akhtar, Parveen S., Khatun, Nazrina, Rahnuma, Parveen, Rashiduzzaman, Ahmed, Ahmed Bux, Rashid, Huang, Guoyu, Ramjiawan, Bram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721278/
https://www.ncbi.nlm.nih.gov/pubmed/31362354
http://dx.doi.org/10.3390/cancers11081069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721278/
https://www.ncbi.nlm.nih.gov/pubmed/31362354
http://dx.doi.org/10.3390/cancers11081069

Ejemplares similares